Citadel Advisors
CRSP icon

Citadel Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$918K Sell
18,878
-238,669
-93% -$11.6M ﹤0.01% 3400
2025
Q1
$8.76M Sell
257,547
-621,349
-71% -$21.1M ﹤0.01% 1336
2024
Q4
$34.6M Buy
878,896
+360,349
+69% +$14.2M 0.01% 688
2024
Q3
$24.4M Buy
518,547
+375,985
+264% +$17.7M ﹤0.01% 766
2024
Q2
$7.7M Sell
142,562
-94,538
-40% -$5.11M ﹤0.01% 1387
2024
Q1
$16.2M Sell
237,100
-36,259
-13% -$2.47M ﹤0.01% 1006
2023
Q4
$17.1M Buy
273,359
+251,804
+1,168% +$15.8M ﹤0.01% 922
2023
Q3
$978K Sell
21,555
-66,410
-75% -$3.01M ﹤0.01% 3063
2023
Q2
$4.94M Sell
87,965
-86,374
-50% -$4.85M ﹤0.01% 1733
2023
Q1
$7.89M Buy
174,339
+4,425
+3% +$200K ﹤0.01% 1470
2022
Q4
$6.91M Buy
169,914
+164,324
+2,940% +$6.68M ﹤0.01% 1537
2022
Q3
$365K Sell
5,590
-2,618
-32% -$171K ﹤0.01% 4369
2022
Q2
$499K Sell
8,208
-203,205
-96% -$12.4M ﹤0.01% 4140
2022
Q1
$13.3M Buy
211,413
+77,094
+57% +$4.84M ﹤0.01% 1196
2021
Q4
$10.2M Sell
134,319
-83,702
-38% -$6.34M ﹤0.01% 1442
2021
Q3
$24.4M Buy
218,021
+174,687
+403% +$19.6M 0.01% 795
2021
Q2
$7.02M Sell
43,334
-232,439
-84% -$37.6M ﹤0.01% 1781
2021
Q1
$33.6M Buy
275,773
+209,209
+314% +$25.5M 0.01% 662
2020
Q4
$10.2M Buy
66,564
+32,291
+94% +$4.94M ﹤0.01% 1248
2020
Q3
$2.87M Buy
34,273
+20,968
+158% +$1.75M ﹤0.01% 1948
2020
Q2
$978K Sell
13,305
-19,344
-59% -$1.42M ﹤0.01% 2881
2020
Q1
$1.39M Sell
32,649
-174,609
-84% -$7.41M ﹤0.01% 2563
2019
Q4
$12.6M Buy
+207,258
New +$12.6M 0.01% 1049
2019
Q3
Hold
0
4722
2019
Q2
Hold
0
4699
2019
Q1
Sell
-61,508
Closed -$1.76M 4585
2018
Q4
$1.76M Buy
61,508
+33,233
+118% +$949K ﹤0.01% 2330
2018
Q3
$1.25M Sell
28,275
-67,206
-70% -$2.98M ﹤0.01% 2536
2018
Q2
$5.61M Buy
95,481
+41,785
+78% +$2.46M ﹤0.01% 1331
2018
Q1
$2.45M Buy
53,696
+13,885
+35% +$635K ﹤0.01% 1791
2017
Q4
$935K Buy
+39,811
New +$935K ﹤0.01% 2429